Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000013140
JPRN-UMIN000013140Completed未知

Phase one/two study of focal salvage high-dose-rate brachytherapy for patient with PSA-failure after radiotherapy for prostate cancer - Salvage high-dose-rate brachytherapy for local recurrent prostate cancer

Kawasaki Medical School0 sites30 target enrollmentStarted: February 24, 2014Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
30
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
45years-old to 80years-old (—)
Sex
Male

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •prostate cancer with hormon reflactoly

Investigators

Similar Trials

Completed
Not Applicable
Phase one/two study of focal salvage high-dose-rate brachytherapy for patient with PSA-failure after radiotherapy for prostate cancerlocal relapse case with prostate cancer after radiotherapy
JPRN-UMIN000006734Department of Radiation Oncology,Kawasaki Medical School10
Completed
Phase 1
Clinical trial to evaluate safety, tolerability and pharmacokinetic of herbal (ICB-014-A002) capsule in healthy adult volunteers.
CTRI/2018/01/011259Indian Institute of Integrative Medicine Council of Scientific Industrial Research38
Active, not recruiting
Phase 1
A clinical gene therapy study with hematopoietic stem cells for the treatment of patients suffering from a plasma cell tumor.Multiple myeloma in early relapse after intensive front line therapyMedDRA version: 20.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864
EUCTR2018-001741-14-ITOSPEDALE SAN RAFFAELE3
Completed
Not Applicable
A PHASE I/II DOSE-FINDING STUDY OF HIGH-DOSE FLUCONAZOLE TREATMENT IN AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS-B24 Unspecified human immunodeficiency virus [HIV] diseaseUnspecified human immunodeficiency virus [HIV] diseaseB24
PER-030-10INSTITUTO NACIONAL DE ALERGIAS Y ENFERMEDADES INFECCIOSAS DE LOS ESTADOS UNIDOS, SOCIAL & SCIENTIFIC SYSTEMS, INC,,
Active, not recruiting
Not Applicable
A prospective phase II study on dose escalation using PET based adaptive IMRT stage II-III non small lung cancerStage II-III Non small lung cancer
EUCTR2011-003124-12-BECliniques Universitaires Saint Luc